- Harrow Will Release First Quarter 2024 Financial Results After Market Close on May 13, 2024
- Melt Pharmaceuticals Closes $24 Million Series B Preferred Stock Financing
- Harrow Announces Fourth Quarter and Year-End 2023 Financial Results
- Harrow Will Release Fourth Quarter and Year-End 2023 Financial Results After Market Close on March 19, 2024
- Harrow Licenses Canadian Rights to Apotex for Five Branded Ophthalmic Pharmaceutical Products
More ▼
Key statistics
On Friday, Harrow Inc (HROW:NMQ) closed at 11.60, 52.63% above the 52 week low of 7.60 set on Nov 14, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 10.30 |
---|---|
High | 11.61 |
Low | 10.20 |
Bid | 11.60 |
Offer | 12.78 |
Previous close | 10.29 |
Average volume | 361.60k |
---|---|
Shares outstanding | 35.38m |
Free float | 30.22m |
P/E (TTM) | -- |
Market cap | 364.08m USD |
EPS (TTM) | -0.7448 USD |
Data delayed at least 15 minutes, as of May 10 2024 21:00 BST.
More ▼